Prescription Refill Gap of Endocrine Treatment from Electronic Medical Records as a Prognostic Factor in Breast Cancer Patients.
Yura LeeYu-Rang ParkIl-Young ChungSae Byul LeeIl Yong ChungByung Ho SonSei Hyun AhnJong Won LeePublished in: Journal of breast cancer (2019)
A gap of > 4 weeks in hormonal treatment has negative effects on breast cancer prognosis, and can hence be used as a sentinel index of higher risk due to treatment non-adherence. Further evaluation is needed to determine whether the gap can be used as a universal index for monitoring the adherence to hormonal treatment.